Drug Type Recombinant protein |
Synonyms YN 203, YN203 |
Target |
Mechanism GCGR antagonists(Glucagon receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | CN | 22 Nov 2023 |